What is the pipeline for future medications for obesity? International Journal of Obesity Cagrilintide and semaglutide together drive record weight loss in global trial Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Retatrutide vs Mounjaro (Tirzepatide): Which is Better? CagriSema vs. Tirzepatide: Which One MELTS Fat Faster? Dr. Dan Obesity Expert Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link